1 Min Read
May 11 (Reuters) - Bayer AG:
* EYLEA GAINS APPROVAL IN CHINA FOR TREATMENT OF VISUAL IMPAIRMENT DUE TO NEOVASCULAR (WET) AGE-RELATED MACULAR DEGENERATION Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.